Drug · DIN 02467437
M-EZETIMIBE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 14, 2017; first marketed December 14, 2017.
- Drug Identification Number (DIN)
- 02467437
- Company (DIN owner)
- Mantra Pharma Inc.Brossard, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- September 9, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 18, 2017: NOC 19685Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies